Correct the message
Change a life
A new class of gene therapies that
correct dysfunctional messenger RNA
Correct the message
Change a life
A new class of gene therapies that
correct dysfunctional messenger RNA

A new advance
in genetic medicines

Locanabio is pioneering a new class of targeted therapies that specifically corrects dysfunctional RNA, the root cause of many devastating genetic diseases. By combining the specificity of RNA-binding proteins with the durable effect of a one-time gene therapy, we can address the underlying RNA defects in patients suffering from rare neuromuscular, neurodegenerative and retinal diseases.

Powerful
Platform

Learn how our science targets the RNA dysfunction of severe diseases

Partnership
Opportunities

Build a valuable partnership with us—adjusting our platform to advance your programs

Inspiring
Careers

Explore exciting careers at a company committed to making a positive difference in lives